Silencing mouse circular RNA circSlc8a1 by circular antisense cA-circSlc8a1 induces cardiac hepatopathy
Molecular Therapy · 2023-06 · 31 (6) · 1688-1704
DOI: 10.1016/j.ymthe.2022.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2023-06. Verfasst von Nan Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sunnybrook Research Institute, Toronto, ON M4N3M5, Canada. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Heart Failure, RNA, Antisense, RNA, Circular. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research, Sunnybrook Research Institute.
Abstract (Originalsprache)
Circular RNAs (circRNAs) are a group of non-coding RNAs with a unique circular structure generated by back-splicing. It is acknowledged that circRNAs play critical roles in cardiovascular diseases. However, functional studies of circRNAs were impeded due to lack of effective in vivo silencing approaches. Since most circRNAs are produced by protein-coding transcripts, gene editing typically affects the coding activity of the parental genes. In this study, we developed a circular antisense RNA (cA-circSlc8a1) that could silence the highly expressed circRNA circSlc8a1 in the mouse heart but not its parental Slc8a1 linear mRNA. Transgenic cA-circSlc8a1 mice developed congestive heart failure resulting in a significant increase in the body weight secondary to peripheral edema and congestive hepatopathy. To further test the role of circSlc8a1, we generated transgenic mice overexpressing circSlc8a1 and observed a protective effect of circSlc8a1 in a pressure overload model. Mechanistically, we found that circSlc8a1 translocated into mitochondria to drive ATP synthesis. While establishing a transgenic murine model for antisense-mediated circRNA silencing without interfering with the parental linear RNA, our finding revealed the essential role of circSlc8a1 in maintaining heart function and may lay the groundwork of using the circular antisense RNA as a potential gene therapy approach for cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sunnybrook Research Institute, Toronto, ON M4N3M5, Canada.
- Sunnybrook Research Institute, Toronto, ON M4N3M5, Canada; Department of Medical Lab Technology, the University of Haripur (UOH), Haripur, Pakistan.
- Sunnybrook Research Institute, Toronto, ON M4N3M5, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. Electronic address: byang@sri.utoronto.ca.
Förderung
- Canadian Institutes of Health Research
- Sunnybrook Research Institute
Zitieren
APA
Wu, N., Li, F., Yang, W., Du, W. W., Awan, F. M., Zhang, C., Lyu, J., Misir, S., Zeng, K., Eshaghi, E., & Yang, B. B. (2023). Silencing mouse circular RNA circSlc8a1 by circular antisense cA-circSlc8a1 induces cardiac hepatopathy. Molecular Therapy, 31(6), 1688-1704. https://doi.org/10.1016/j.ymthe.2022.10.005
Vancouver
Wu N, Li F, Yang W, Du WW, Awan FM, Zhang C, et al. Silencing mouse circular RNA circSlc8a1 by circular antisense cA-circSlc8a1 induces cardiac hepatopathy. Molecular Therapy. 2023;31(6):1688-1704. doi:10.1016/j.ymthe.2022.10.005
BibTeX
@article{Wu2023,
author = {Wu, Nan and Li, Feiya and Yang, Weining and Du, William W and Awan, Faryal Mehwish and Zhang, Chao and Lyu, Juanjuan and Misir, Sema and Zeng, Kaixuan and Eshaghi, Esra and Yang, Burton B},
title = {Silencing mouse circular RNA circSlc8a1 by circular antisense cA-circSlc8a1 induces cardiac hepatopathy},
journal = {Molecular Therapy},
year = {2023},
volume = {31},
number = {6},
pages = {1688--1704},
doi = {10.1016/j.ymthe.2022.10.005}
}
EUVIMED